https://biotechpharmainvestor.substack.comBackground: Physician involved in clinical research. Investment style: Clinical-stage biotech stocks, long only, both long-term ideas and event-driven trading. My academic/medical background helps me evaluate the scientific fundamentals of biotech stocks.Due to seeking alpha rules I cannot cover here all stocks that I am following/trading. I write about such stock in substack.Analyst’s Disclosure:I/we have a beneficial long position in the shares of DTIL either thro ...

Core Viewpoint - The article discusses the investment strategy focused on clinical-stage biotech stocks, emphasizing the importance of scientific fundamentals in evaluating these investments [1]. Group 1: Investment Strategy - The investment style is long-only, targeting both long-term ideas and event-driven trading opportunities within the biotech sector [1]. - The author’s academic and medical background aids in assessing the scientific fundamentals of biotech stocks, which is crucial for making informed investment decisions [1]. Group 2: Analyst's Position - The analyst holds a beneficial long position in the shares of DTIL, indicating confidence in the stock's potential [2]. - The article reflects the author's personal opinions and is not influenced by compensation from any company mentioned [2].